CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 116 filers reported holding CLOVIS ONCOLOGY INC in Q3 2013. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $58,368,000 | +100.7% | 634,718 | +91.8% | 0.03% | +8.3% |
| Q2 2015 | $29,082,000 | +19.4% | 330,929 | +0.8% | 0.02% | +20.0% |
| Q1 2015 | $24,366,000 | -13.7% | 328,253 | -34.9% | 0.02% | -16.7% |
| Q4 2014 | $28,231,000 | +153.5% | 504,123 | +87.4% | 0.02% | +140.0% |
| Q2 2014 | $11,138,000 | -36.1% | 268,977 | +6.8% | 0.01% | -37.5% |
| Q1 2014 | $17,441,000 | +60.3% | 251,789 | +39.5% | 0.02% | +60.0% |
| Q4 2013 | $10,880,000 | +13.3% | 180,529 | +14.2% | 0.01% | 0.0% |
| Q3 2013 | $9,607,000 | +23.5% | 158,065 | +36.0% | 0.01% | +25.0% |
| Q2 2013 | $7,782,000 | – | 116,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |